Article
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
1 Nov 2012
Abstract excerpt
BACKGROUND: Resistance to cisplatin-based chemotherapy is associated with poor prognosis in testicular germ cell cancer, emphasising the need for new therapeutic approaches. In this respect, the therapeutic concept of anti-angiogenesis is of particular interest. In a previous study, we presented two novel anti-angiogenic compounds, HP-2 and HP-14, blocking the tyrosine kinase activity of angiogenic growth factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
